Abstract:
Rheumatoid arthritis is a severe, chronic, infl ammatory
disorder, that typically affect small joints, with subsequently
loss of function of the affected joints and lead to disability.Rheumatoid arthritis has a possible systemic involvement,
which leads to reduction of life-expectancy, which in some
studies amounts 5-10 years. The key point of our study is
that tocilizumab is an effective treatment of rheumatoid
arthritis, the majority of patients treated with tocilizumab
had an obvious improvement in remission criteria.